Literature DB >> 6480113

Lack of cross-reactivity of antibodies to ribosomal preparations from Streptococcus mutans with human heart and kidney antigens.

R L Gregory, I L Shechmeister, J O Brubaker, C T Smedberg, S M Michalek, J R McGhee.   

Abstract

Previous studies have suggested that sera from animals immunized with whole Streptococcus mutans cells may cross-react with human and monkey heart sarcolemmal tissues. In the present study, sera and saliva from rats and rabbits immunized peripherally with ribosomal preparations from S. mutans 6715 (serotype g) or GS-5 (serotype c) were examined for their ability to react with normal human heart sarcolemmal and kidney glomerular tissues by using enzyme-linked immunosorbent and immunofluorescence assays. The results showed that antibodies to serotype g and c ribosomal preparations do not react with either the human heart or renal antigens. Sera from mice immunized with human heart tissue and from a patient with a high anti-streptolysin O titer reacted strongly with human heart sarcolemmal and kidney glomerular tissues. These data indicated that ribosomal preparations from S. mutans lack the putative human heart cross-reactive determinant and suggest that the use of an S. mutans ribosomal vaccine against dental caries may not be pathogenic to human heart or renal tissues.

Entities:  

Mesh:

Year:  1984        PMID: 6480113      PMCID: PMC261418          DOI: 10.1128/iai.46.1.42-47.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Association of Streptococcus mutants with human dental decay.

Authors:  W J Loesche; J Rowan; L H Straffon; P J Loos
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441

Review 2.  Reevaluation of experiments intended to demonstrate immunological cross-reactions between mammalian tissues and streptococci.

Authors:  P Christensen; C Schalén; S E Holm
Journal:  Prog Allergy       Date:  1979

3.  Factors affecting immunogenic activity of mycobacterial ribosomal and ribonucleic acid preparations.

Authors:  A S Youmans; G P Youmans
Journal:  J Bacteriol       Date:  1969-07       Impact factor: 3.490

4.  Dental caries: prospects for prevention.

Authors:  H W Scherp
Journal:  Science       Date:  1971-09-24       Impact factor: 47.728

Review 5.  Immunobiology of dental caries: microbial aspects and local immunity.

Authors:  J R McGhee; S M Michalek
Journal:  Annu Rev Microbiol       Date:  1981       Impact factor: 15.500

6.  Antigens in Streptococcus mutans cross reactive with human heart muscle.

Authors:  I Van de Rijn; A S Bleiweis; J B Zabriskie
Journal:  J Dent Res       Date:  1976-04       Impact factor: 6.116

7.  Immunological cross-reactivity of oral non-streptococcal bacteria with mammalian tissue.

Authors:  M W Stinson; R J Nisengard; L Pelonero; A J Drinnan
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

8.  Humoral and cell-mediated responses to a ribosomal preparation from Streptococcus mutans.

Authors:  R L Gregory; I L Shechmeister
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

9.  Enhancement of murine immune responses to orally administered haptenated Streptococcus mutans.

Authors:  H Kiyono; S M Michalek; L M Mosteller; M Torii; S Hamada; J R McGhee
Journal:  Scand J Immunol       Date:  1982-12       Impact factor: 3.487

10.  Longitudinal investigation of the role of Streptococcus mutans in human fissure decay.

Authors:  W J Loesche; L H Straffon
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

View more
  2 in total

1.  Characterization of immune response to oral administration of Streptococcus sobrinus ribosomal preparations in liposomes.

Authors:  R L Gregory; S M Michalek; G Richardson; C Harmon; T Hilton; J R McGhee
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

2.  Protective secretory immunoglobulin A antibodies in humans following oral immunization with Streptococcus mutans.

Authors:  R L Gregory; S J Filler
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.